DE69820239T2 - Cisplatinhaltige mikrogranulate - Google Patents

Cisplatinhaltige mikrogranulate Download PDF

Info

Publication number
DE69820239T2
DE69820239T2 DE69820239T DE69820239T DE69820239T2 DE 69820239 T2 DE69820239 T2 DE 69820239T2 DE 69820239 T DE69820239 T DE 69820239T DE 69820239 T DE69820239 T DE 69820239T DE 69820239 T2 DE69820239 T2 DE 69820239T2
Authority
DE
Germany
Prior art keywords
cisplatine
microgranules containing
microgranules
containing cisplatine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69820239T
Other languages
German (de)
English (en)
Other versions
DE69820239D1 (de
Inventor
Patrice Debregeas
Gerard Leduc
Pascal Oury
Pascal Suplie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethypharm SAS
Original Assignee
Ethypharm SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm SAS filed Critical Ethypharm SAS
Publication of DE69820239D1 publication Critical patent/DE69820239D1/de
Application granted granted Critical
Publication of DE69820239T2 publication Critical patent/DE69820239T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69820239T 1997-02-11 1998-02-10 Cisplatinhaltige mikrogranulate Expired - Lifetime DE69820239T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9701545A FR2759293B1 (fr) 1997-02-11 1997-02-11 Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
PCT/FR1998/000251 WO1998034599A1 (fr) 1997-02-11 1998-02-10 Microgranules contenant du cisplatine

Publications (2)

Publication Number Publication Date
DE69820239D1 DE69820239D1 (de) 2004-01-15
DE69820239T2 true DE69820239T2 (de) 2004-10-07

Family

ID=9503556

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69820239T Expired - Lifetime DE69820239T2 (de) 1997-02-11 1998-02-10 Cisplatinhaltige mikrogranulate

Country Status (24)

Country Link
US (2) US6458389B1 (https=)
EP (1) EP0971702B1 (https=)
JP (1) JP4549445B2 (https=)
KR (1) KR100471672B1 (https=)
AR (1) AR011133A1 (https=)
AT (1) ATE255409T1 (https=)
BG (1) BG64247B1 (https=)
BR (1) BR9807319A (https=)
CA (1) CA2282082C (https=)
DE (1) DE69820239T2 (https=)
DK (1) DK0971702T3 (https=)
EA (1) EA001760B1 (https=)
ES (1) ES2210726T3 (https=)
FR (1) FR2759293B1 (https=)
HU (1) HU225425B1 (https=)
IL (1) IL131326A (https=)
IN (1) IN187998B (https=)
NO (1) NO323230B1 (https=)
NZ (1) NZ337216A (https=)
PL (1) PL191631B1 (https=)
PT (1) PT971702E (https=)
TW (1) TW561055B (https=)
WO (1) WO1998034599A1 (https=)
ZA (1) ZA981123B (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050096304A1 (en) * 1998-09-08 2005-05-05 David White Method of treating cancer using dithiocarbamate derivatives
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
BR0010649A (pt) * 1999-05-17 2002-02-19 D B F Grãnulos que contêm pelo menos uma substância vegetal e processo de preparação dos mesmos
KR101148734B1 (ko) * 2003-10-10 2012-07-05 에띠빠흠 징코 빌로바 추출물을 포함하는 서방형 미세과립 및 이것을 제조하는 방법
FR2861990B1 (fr) * 2003-11-10 2006-02-10 Nouveaux Produits Pharma Comprimes faiblement doses a reseau de polymeres
AR052142A1 (es) * 2004-11-18 2007-03-07 Bristol Myers Squibb Co Perla recubierta enterica que comprende ixabepilona, y preparacion y administracion de la misma
EP1832293A4 (en) * 2004-12-10 2009-01-07 Tmrc Co Ltd MEANS FOR THE TREATMENT OF CANCER METASTAS AND CANNESMAS TREATMENT
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
FR2918566B1 (fr) 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
SI2187875T1 (sl) * 2007-09-21 2012-12-31 Evonik Rohm Gmbh Od pH odvisen farmacevtski sestavek z nadzorovanim sproščanjem za ne-opioide z odpornostjo na vpliv etanola
CN101801357B (zh) * 2007-09-21 2013-08-07 赢创罗姆有限公司 耐受乙醇的影响的pH依赖性受控释放的药物组合物
BRPI0821985A2 (pt) * 2008-01-10 2015-06-23 Evonik Roehm Gmbh Preparacao farmacêutica ou nutracêutica revestida tendo liberação de substância ativa controlada
WO2009086940A1 (en) * 2008-01-10 2009-07-16 Evonik Röhm Gmbh Coated pharmaceutical or nutraceutical preparation with enhanced active substance release in the colon
DK177529B1 (en) * 2009-10-23 2013-09-08 Bio Bedst Aps Liposomes with improved storage stability
CA2688202C (en) * 2009-12-11 2012-11-13 Bj Services Company Viscoelastic fluids containing hydroxyethyl cellulose
EP2371356B1 (en) * 2010-03-12 2012-12-19 Phoeme GmbH Multi-particle pharmaceutical formulation for colon absorption
US8070047B1 (en) * 2010-12-02 2011-12-06 Rohm And Haas Electronic Materials Llc Flux composition and method of soldering
CN121606602A (zh) 2012-09-04 2026-03-06 埃莱森制药股份有限公司 用顺铂脂质复合物预防癌症的肺部复发
KR20170052626A (ko) 2014-09-05 2017-05-12 심바이오믹스 세러퓨틱스 엘엘씨 세균질증 치료에 사용하기 위한 세크니다졸
US10238688B2 (en) * 2015-04-24 2019-03-26 Genedia Biotech Co., Ltd. Combination therapies for bladder cancer
CA2988082C (en) * 2015-06-01 2020-09-29 Symbiomix Therapeutics, Llc Novel nitroimidazole formulations and uses thereof
WO2016200951A1 (en) 2015-06-12 2016-12-15 Vaxart, Inc. Formulations for small intestinal delivery of rsv and norovirus antigens
TWI795462B (zh) 2017-11-17 2023-03-11 日商鹽野義製藥股份有限公司 光安定性及溶出性優異的醫藥製劑
MX395463B (es) * 2018-04-24 2025-03-25 Shionogi & Co Forma de dosificacion solida que tiene excelente estabilidad
KR102501180B1 (ko) 2018-04-24 2023-02-21 시오노기세야쿠 가부시키가이샤 안정성이 우수한 고형 제제
US12280037B2 (en) 2020-09-22 2025-04-22 Evofem Biosciences, Inc. Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE15971T1 (de) * 1981-03-11 1985-10-15 Mirko Beljanski Serpentin, alstonin und sempervirin, medikamente, die die tumor- und krebszellen spezifisch hemmen.
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
DE3523454A1 (de) * 1985-07-01 1987-01-08 Eberhard Prof Dr Nuernberg Formkoerper
US4925674A (en) * 1988-08-25 1990-05-15 Himedics, Inc. Amoxicillin microencapsulated granules
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
JPH05294839A (ja) * 1992-04-20 1993-11-09 Biomaterial Universe Kk シスプラチン含有生体内分解吸収性高分子の微小球お よびその製造法
US5795882A (en) * 1992-06-22 1998-08-18 Bone Care International, Inc. Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
JPH07112932A (ja) * 1993-08-27 1995-05-02 Mitsui Toatsu Chem Inc 徐放性医薬製剤
JPH0789849A (ja) * 1993-09-20 1995-04-04 Fujisawa Pharmaceut Co Ltd 徐放性製剤
JPH0859460A (ja) * 1994-08-22 1996-03-05 Tanaka Kikinzoku Kogyo Kk 抗ガン剤内包キトサンミクロスフェア及びその製造法
US5637319A (en) * 1995-03-01 1997-06-10 Takada; Kanji Controlled-release preparations
US5614206A (en) * 1995-03-07 1997-03-25 Wright Medical Technology, Inc. Controlled dissolution pellet containing calcium sulfate
CA2263455C (en) * 1996-08-23 2002-10-29 Sequus Pharmaceuticals, Inc. Liposomes containing a cisplatin compound

Also Published As

Publication number Publication date
FR2759293B1 (fr) 1999-04-30
IN187998B (https=) 2002-08-03
FR2759293A1 (fr) 1998-08-14
ES2210726T3 (es) 2004-07-01
AU744001B2 (en) 2002-02-14
ZA981123B (en) 1998-08-20
KR100471672B1 (ko) 2005-03-07
NO323230B1 (no) 2007-02-05
DE69820239D1 (de) 2004-01-15
HU225425B1 (en) 2006-11-28
AR011133A1 (es) 2000-08-02
EP0971702A1 (fr) 2000-01-19
BG64247B1 (bg) 2004-07-30
NO993881D0 (no) 1999-08-11
US20030017210A1 (en) 2003-01-23
IL131326A0 (en) 2001-01-28
CA2282082A1 (fr) 1998-08-13
IL131326A (en) 2005-03-20
EA001760B1 (ru) 2001-08-27
NZ337216A (en) 2000-09-29
PL335107A1 (en) 2000-04-10
EP0971702B1 (fr) 2003-12-03
PL191631B1 (pl) 2006-06-30
ATE255409T1 (de) 2003-12-15
CA2282082C (fr) 2005-10-18
AU6626798A (en) 1998-08-26
EA199900734A1 (ru) 2000-04-24
TW561055B (en) 2003-11-11
US6458389B1 (en) 2002-10-01
NO993881L (no) 1999-09-29
DK0971702T3 (da) 2004-04-13
JP2001512433A (ja) 2001-08-21
BG103647A (en) 2000-03-31
HUP0001719A3 (en) 2005-11-28
PT971702E (pt) 2004-04-30
JP4549445B2 (ja) 2010-09-22
WO1998034599A1 (fr) 1998-08-13
KR20000070997A (ko) 2000-11-25
BR9807319A (pt) 2000-04-18
HUP0001719A2 (hu) 2000-11-28

Similar Documents

Publication Publication Date Title
DE69820239T2 (de) Cisplatinhaltige mikrogranulate
DE69839157D1 (de) Fullurene enthaltendes katherdersystem
FI972714A0 (fi) Foerfarande foer erhaollning av propenterpolymerer
FI971180A7 (fi) Stripe-line-kela
FI973846A0 (fi) Anrop av en mobilabonnent foer att bilda en paketfoerbindelse
FI970156A0 (fi) Foerfarande foer framstaellning av fiberplattor
FI974023A0 (fi) Taetningskonstruktion foer suglaogan av en sugvals i en pappersmaskin/en kartongmaskin
FI971696A0 (fi) Foerfarande foer heat-soak-behandling av haerdade glasskivor
FI970477A0 (fi) Foerfarande foer behandling av en oevantad nedkopplingsbegaeran
FI972800A0 (fi) Behandling av signaleringsmeddelande i ATM-nod
FI973312A0 (fi) Foerfarande foer indikering av en abonnent i en kedjad V5-anslutning
FI973582A0 (fi) Maetning av faedningsmarginal i radiosystem
FI971222A0 (fi) Tillverkning av vaegmaerken
FI971730A0 (fi) Munstyckesarrangemang i blaoslaodan av en pappersmaskin
FI973860A0 (fi) Foerfarande foer saekerstaellande av noedkommunikation i en kedjad V5-anslutning
FI971841A0 (fi) Foerfarande foer framstaellning av bestrykningssmet foer papper
FI972847A0 (fi) Foerfarande foer hantering av aonga i en fibreringsprocess
FI970072A0 (fi) Anordning foer styrning av en lyftkrans lastningsorgan
FI974311A0 (fi) Foerfarande foer centralisering av abonnenter i en lokalcentral
FI973311A0 (fi) Foerfarande foer foermedling av protokollen foer V5-anslutningar i en kedjad V5-anslutning
FI971902A0 (fi) Foerfarande foer behandling av mjoelk
NO20000525L (no) Kombinert transportør
KR970060407U (ko) 운반구
FI972394A0 (fi) Foerfarande foer behandling av draggaser i en loesningsbehaollare av en sodapanna
FI972711A0 (fi) Foerfarande foer bestaemning av ligninhalt i barr- och loevvedsmassa

Legal Events

Date Code Title Description
8364 No opposition during term of opposition